OBJECTIVE: To assess obstetric and neonatal outcomes in women with a prior episode of cancer. METHODS: Data were obtained from a linkage between the Scottish Cancer Registry and routinely collected data from Scottish maternity hospitals. Obstetric outcomes in a first pregnancy which ended between 1980 and 2005 were compared in 917 women with, and 5,496 women without, a previous history of cancer. RESULTS: The mean age at delivery was 29 years (standard deviation 5.66) and 26 years (standard deviation 5.62) in the exposed and unexposed groups respectively (P<.001). Multiple logistic regression showed that cancer survivors had higher rates of postpartum hemorrhage (odds ratio [OR] 1.56, 95% confidence interval [CI] 1.09-2.23) and operative or assisted delivery (abdominal or vaginal) (OR 1.33, 95% CI 1.14- 1.54). Preterm delivery (at less than 37 weeks of gesation) was also found to be higher in this group compared with non-cancer women (OR 1.33, 95% CI 1.01-1.76). CONCLUSION: While largely reassuring to women intending to become pregnant after surviving cancer, the results indicate areas of increased risk that require additional surveillance.
OBJECTIVE: To assess obstetric and neonatal outcomes in women with a prior episode of cancer. METHODS: Data were obtained from a linkage between the Scottish Cancer Registry and routinely collected data from Scottish maternity hospitals. Obstetric outcomes in a first pregnancy which ended between 1980 and 2005 were compared in 917 women with, and 5,496 women without, a previous history of cancer. RESULTS: The mean age at delivery was 29 years (standard deviation 5.66) and 26 years (standard deviation 5.62) in the exposed and unexposed groups respectively (P<.001). Multiple logistic regression showed that cancer survivors had higher rates of postpartum hemorrhage (odds ratio [OR] 1.56, 95% confidence interval [CI] 1.09-2.23) and operative or assisted delivery (abdominal or vaginal) (OR 1.33, 95% CI 1.14- 1.54). Preterm delivery (at less than 37 weeks of gesation) was also found to be higher in this group compared with non-cancerwomen (OR 1.33, 95% CI 1.01-1.76). CONCLUSION: While largely reassuring to women intending to become pregnant after surviving cancer, the results indicate areas of increased risk that require additional surveillance.
Authors: Kathleen P Hartnett; Kevin C Ward; Michael R Kramer; Timothy L Lash; Ann C Mertens; Jessica B Spencer; Amy Fothergill; Penelope P Howards Journal: Int J Cancer Date: 2017-08-24 Impact factor: 7.396
Authors: Laura-Maria Madanat-Harjuoja; Nea Malila; Päivi M Lähteenmäki; John D Boice; Mika Gissler; Tadeusz Dyba Journal: Int J Cancer Date: 2010-10-01 Impact factor: 7.396
Authors: Richard A Anderson; David H Brewster; Rachael Wood; Sian Nowell; Colin Fischbacher; Tom W Kelsey; W Hamish B Wallace Journal: Hum Reprod Date: 2018-07-01 Impact factor: 6.918
Authors: Laura-Maria Madanat-Harjuoja; Päivi M Lähteenmäki; Tadeusz Dyba; Mika Gissler; John D Boice; Nea Malila Journal: Acta Oncol Date: 2013-01-17 Impact factor: 4.089
Authors: Leslie V Farland; Judy E Stern; Sunah S Hwang; Chia-Ling Liu; Howard Cabral; Richard Knowlton; Susan T Gershman; Charles C Coddington; Stacey A Missmer Journal: Cancer Causes Control Date: 2020-11-27 Impact factor: 2.506
Authors: Barbara Buonomo; Roberto Orecchia; Federica Tomao; Lino Del Pup; Alex Garcia-Faura; Fedro A Peccatori Journal: Ecancermedicalscience Date: 2020-05-06